BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22549255)

  • 21. Metabolic and bariatric surgery for obesity: a review.
    Glatt D; Sorenson T
    S D Med; 2011; Spec No():57-62. PubMed ID: 21721189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bariatric surgery: unstressing or boosting the beta-cell?
    Mingrone G; Castagneto M
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():130-42. PubMed ID: 19817795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors of outcome after gastric banding: a nationwide survey on the role of center activity and patients' behavior.
    Chevallier JM; Paita M; Rodde-Dunet MH; Marty M; Nogues F; Slim K; Basdevant A
    Ann Surg; 2007 Dec; 246(6):1034-9. PubMed ID: 18043107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bariatric surgery on type-2 diabetes mellitus in a Caribbean setting.
    Dan D; Harnanan D; Singh Y; Hariharan S; Naraynsingh V; Teelucksingh S
    Int J Surg; 2011; 9(5):386-91. PubMed ID: 21420513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA; Kane MP; Busch RS
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of surgery in the management of obesity-related type 2 diabetes mellitus.
    Gan SS; Talbot ML; Jorgensen JO
    ANZ J Surg; 2007 Nov; 77(11):958-62. PubMed ID: 17931257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential loss of fat and lean mass in the morbidly obese after bariatric surgery.
    Zalesin KC; Franklin BA; Lillystone MA; Shamoun T; Krause KR; Chengelis DL; Mucci SJ; Shaheen KW; McCullough PA
    Metab Syndr Relat Disord; 2010 Feb; 8(1):15-20. PubMed ID: 19929598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bariatric surgery: a cure for diabetes?
    Varela JE
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):396-401. PubMed ID: 21505331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of the metabolic/bariatric surgery patient.
    Buchwald H; Ikramuddin S; Dorman RB; Schone JL; Dixon JB
    Am J Med; 2011 Dec; 124(12):1099-105. PubMed ID: 22014789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bariatric surgery in patients with morbid obesity and type 2 diabetes.
    Schernthaner G; Morton JM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S297-302. PubMed ID: 18227500
    [No Abstract]   [Full Text] [Related]  

  • 31. Bariatric surgery in patients with type 2 diabetes: a viable option.
    Colucci RA
    Postgrad Med; 2011 Jan; 123(1):24-33. PubMed ID: 21293081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An unusual picture of insulinoma in type-2 diabetes mellitus and morbid obesity].
    Wildbrett J; Nagel M; Theissig F; Gaertner HJ; Gromeier S; Fischer S; Hanefeld M
    Dtsch Med Wochenschr; 1999 Mar; 124(9):248-52. PubMed ID: 10102010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolic surgery].
    Fried M
    Vnitr Lek; 2010 Oct; 56(10):1065-8. PubMed ID: 21105453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
    Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
    Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database.
    Demaria EJ; Winegar DA; Pate VW; Hutcher NE; Ponce J; Pories WJ
    Ann Surg; 2010 Sep; 252(3):559-66; discussion 566-7. PubMed ID: 20739857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
    Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients.
    Gould JC; Garren MJ; Boll V; Starling JR
    Surgery; 2006 Oct; 140(4):524-9; discussion 529-31. PubMed ID: 17011899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success?
    Frezza EE
    Obes Surg; 2004 Aug; 14(7):999-1005. PubMed ID: 15329192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State intervention in life-threatening childhood obesity.
    Murtagh L; Ludwig DS
    JAMA; 2011 Jul; 306(2):206-7. PubMed ID: 21750301
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interdisciplinary European guidelines on surgery for severe obesity].
    Fried M; Hainer V; Basdevant A; Buchwald H; Dietel M; Finer N; Greve JW; Horber F; Mathus-Vliegen E; Scopinaro N; Steffen R; Tsigos C; Weiner R; Widhalm K
    Rozhl Chir; 2008 Sep; 87(9):468-76. PubMed ID: 19174948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.